○Takehiro Katano1,2, Kentaro Suzuki2, Jyunya Aoki2, Yasuhiro Nishiyama2, Kazumi Kimura2 (1.Department of Neurology, Saitama Cardiovascular and Respiratory Center, Japan, 2.Department of Neurology, Nippon Medical School Hospital, Japan)
Session information
Oral Session
[O-19] Oral Session 19 Clinical trial and Regenerative medicine1
Thu. May 20, 2021 9:45 AM - 10:45 AM Room 09 (ICC Kyoto 1F Sakura Hall)
Chair:Okada Yasushi(Department of Cerebrovascular Disease and Neurology, National Hospital Organization Kyushu Medical Center)
○Hiroaki Yokote1,3, Yusei Miyazaki2, Shuta Toru1, Yoichiro Nishida3, Takaaki Hattori3, Masaaki Niino2, Nobuo Sanjo3, Takanori Yokota3 (1.Department of Neurology, Nitobe Memorial Nakano General Hospital, Japan, 2.Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, 3.Department of Neurology and Neurological Sciences, Tokyo Medical and Dental University, Japan)
○Kazumi Kimura1, Kentarou Suzuki1, Yuji Matsumaru2, Skip study1 (1.Department of Neurology, Nippon Medical School, Japan, 2.Division of Stroke Prevention and Treatment, Department of Neurosurgery)
○Hajime Yoshimura1, Tomotaka Tanaka2, Kazuki Fukuma2, Daisuke Onozuka3, Kunihiro Nishimura3, Michi Kawamoto1, Nobuo Kohara1, Masafumi Ihara2, the PROPOSE study investigators1,2,3 (1.Department of Neurology, Kobe City Medical Center General Hospital, Japan, 2.Department of Neurology, National Cerebral and Cardiovascular Center Hospital, 3.Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center Research Institute)